Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

featured

Published in Dermatology

Expert Opinion / Interview · June 20, 2013

Treatment Options for Infantile Hemangiomas

Only registered members have full access to PracticeUpdate content.

Join for free

Léauté-Labrèze C, Dumas de la Roque E, Hubiche T, et al. Propranolol for severe hemangiomas of infancy. N Engl J Med. 2008;358(24):2649-2651.
Leaute-Labrèze C, Frieden IJ. Propranolol in Infantile Hemangiomas: Results from an International Randomized, Placebo-Controlled, Multidose Adaptive Phase 2/3 Study. Paper presented at: 25th Annual Pre–American Academy of Dermatology Meeting; February 28, 2013; Miami, FL.
Drolet BA, Frommelt PC, Chamlin SL, et al. Initiation and use of propranolol for infantile hemangioma: report of a consensus conference. Pediatrics. 2013;131(1):128–140.
Metry D, Frieden IJ, Hess C, et al. Propranolol use in PHACE syndrome with cervical and intracranial arterial anomalies: collective experience in 32 infants. Pediatr Dermatol. 2013;30(1):71–89.